personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
We take a deep dive into the cell therapy sector in our cover feature and ask what progress is being made in the fight against solid tumors. Meanwhile in NextGen, researchers from Carnegie Mellon University explain how AI can be used to source new pharmaceutical compounds derived from natural sources. Pierre Bourdage, Global Head of Biopharmaceuticals at Sandoz, also gives his take on the future of biosimilars, in Business. We also sit down with Andrew Moore, who tells us how he has used his military experience to inform his approach to leadership in the pharmaceutical industry.